DICE Therapeutics, Inc. Annual Depreciation in USD from 2021 to 2022

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: DICE Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2021 to 2022.
DICE Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $244K, a 61.6% increase year-over-year.
DICE Therapeutics, Inc. annual Depreciation for 2022 was $825K, a 24.8% increase from 2021.

Depreciation, Annual (USD)

Depreciation, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$825K	+$164K	+24.8%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-15
2021	$661K			Jan 1, 2021	Dec 31, 2021	10-K	2023-03-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.